Addex Therapeutics

Caltag Medsystems (CML) has Four Business Divisions:

1. Distribution of Bioscience and Biomedical reagents and kits to the European markets. Key customer groups are Universities, Hospitals, Pharmaceutical Companies, Biotechnology Companies, Private Laboratories. Caltag Medsystems represents over 50 overseas manufacturers from all quarters of the globe. We are looking for new suppliers who fit with our product portfolio and business strategy.
The Cell Culture section of our portfolio includes human and animal primary cells, stem cells, cell lines and media, skin, healthy & diseased human biological materials, angiogenesis models and transfection reagents. Sample types include blood, plasma, serum, bone marrow, CSF, urine, synovial fluid and many more, and are available as matched samples where needed. We supply reagents for the detection of a wide range of different disease biomarkers, together with primary cells and tissue from 26 different cell systems in the human body. Our human biological materials range is extensive, encompassing a wide range of sample types from normal and diseased individuals.
ELISA Kits, Antibodies, Biochemicals and Small Molecules. We provide over 18,000 ELISA kits across a wide range of disease biomarkers including those for apoptosis, cardiovascular, infection and immunity, cytokine and metabolism research and many more. Antibodies, proteins and controls are also available individually.

2. Cytomark Division (www.cytomark.co.uk) - manufacturer of TransFix for stabilisation of whole blood, cerebrospinal fluid, bone marrow and biopsy samples.

3. Cellworks Division (www.cellworks.co.uk) - manufacturer of primary cell models, primary cells, medium and other primary cell reagents. The Cellworks Division is looking for distributors in countries not already represented on our website.

4. Laboratory Services - CRO laboratory services such as Cell Expansion, Flow Cytometry and Angiogenesis service.

ChromaCon AG is a private Swiss Life Science tool company, developing and commercializing proprietary chromatographic process technology.

Our vision is to transform bioprocessing to continuous and our mission is to provide best-in-class tools consisting of equipment, reagents and discovery technologies to help our customers to create, develop and manufacture next-generation chemical and biological medicines.

We facilitate the conversion from batch to more efficient continuous processes by offering equipment, processes and software designed to ease the conversion from batch to continuous chromatography.

We are unique in providing laboratory-scale FPLC and HPLC equipment for the purification of proteins and small molecules. The systems have multiple process capabilities allowing our customers to choose the best purification process for any given purification challenge:

• conventional batch and two-step connected batch for efficient high throughput batch purification
• periodic countercurrent processes (PCC) for continuous capture and polish purification
• novel processes for discovery applications facilitating the isolation of minor components from complex mixtures

Continuous manufacturing offers 30-50% reduction in CAPEX and OPEX compared to conventional batch manufacturing and is emerging to replace batch manufacturing. ChromaCon is unique in having a full range of process and process control patents and offering together with its scale-up partner a one-stop solution from laboratory to GMP process scale.

Anapharm Bioanalytics is a customer-focused bioanalytical CRO specialized in small and large molecule bioanalysis. Led by a team with over 30 years’ experience in method development, validation and sample analysis, we support drug development programs for the pharmaceutical, biotechnological and generic industries worldwide.

Equipped with state-of-the-art LC-MS/MS and LBA technology platforms, Anapharm Bioanalytics provides an array of services including PK studies, biomarker testing and immunogenicity assays throughout preclinical and clinical stages. Our global network of partners allows us to provide full-service outsourcing solutions to conduct preclinical, Phase I-IV clinical trials, and bioequivalence studies for international registration.

Our clients benefit from a deep scientific expertise combined with a robust quality system. All our activities are compliant with GLP and GCP, having undergone 20 regulatory inspections by the FDA, several EU Health Authorities and ANVISA (Brazil).

Whether your drug candidate is a new chemical entity, a new biologic, a generic or a biosimilar, do not hesitate to contact us at info@anapharmbioanalytics.com.

Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.

We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.

For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Quality Assistance S.A. is an expert for the development of:
- Biologics (monoclonal antibodies, ADCs, proteins)
- New Chemical Entities, oligonucleotides, peptides
- Nanomedicine products
- Vaccines
- Cell-Based and Gene Therapy Medicinal Products

The company holds a unique position on the market with:
All its laboratories on one site (Donstiennes, Belgium)
- Bioanalysis (PK/TK/Immuno)
- Bioassays
- Biochemistry
- Chromatography
- Elemental Impurities
- Mass Spectrometry
- Microbiology
- Molecular Biology
- Protein Characterisation
200 highly qualified professionals
more than 35 years’ expertise at the forefront of analytical sciences.

Our core competencies are:
QUALITY (CMC)
- Development and validation of analytical methods
- Characterisation
- Stability studies
- Batch (release) testing
SAFETY/EFFICACY (Bioanalysis)
- Development and validation of bioanalytical methods
- PK/TK studies
- Immunogenicity studies
- Biomarker studies

The Quality Assistance environment is GMP, GLP and GCLP/GCP compliant.

Visit www.quality-assistance.com for more information

GEM FORLAB gives continuity to the experience of ABLE Biosciences as a global provider of scientific technology and services to the Life Science industry. It delivers solutions to companies of all size and shapes.
GEM FORLAB performs its activities by means of three technology areas:
Organic Chemistry
Mass Spectrometry & Proteomics
Cell and Molecular Biology & Immunoassay

ABLE Biosciences is the Test Facility GLP certified for small and large molecules quantitative analysis in biological matrices by means of Mass Spectrometry, Immunometric assays and qPCR and it is included in OsSC register of Private Laboratories qualified to perform analysis on samples derived from drug clinical trials (phase I-II-III) in compliance with GCP.

The Chemistry Unit provides all essential components for early drug discovery such as synthesis of chemical intermediates, process impurities, reference compounds, drug metabolites, and pro-drug; lead generation and optimization; bioconjugate chemistry; targeted molecules for MRI and others Molecular Imaging techniques.